Amoxicillin is an antibiotic which specifically treats bacterial infections. Amoxicillin comes under the Penicillin category of antibiotics, under the class of Beta Lactam and Amino Penicillin. It is a widely prescribed and used antibiotics, generally given with the combination of Clavulanic Acid. As per the World Health Organization (WHO), Amoxicillin and Amoxicillin in combination with Clavulanic Acid are the most frequently used antibiotics globally.

Read Report Overview – https://www.transparencymarketresearch.com/amoxicillin-market.html

Amoxicillin is used in a number of bacterial infections, such as, respiratory tract infections, middle ear infections, pneumonia, urinary tract infections, skin infections, and dental infections. It works on the principle of inhibiting the growth of bacterial wall synthesis. Amoxicillin is prescribed mostly to children for antibacterial purposes and should be avoided in patients allergic to Penicillin.

Rise in prevalence of infectious diseases and growing awareness of various diseases and their treatment are the major factors contributing to the growth of the global Amoxicillin market. According to the WHO, in 2013, pneumonia was responsible for one-fifth of the deaths among children globally and around 1.1 million children die due to pneumonia every year. In every 30 seconds, a child of less than five years of age dies due to pneumonia in the world.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=54807

According to the National Kidney Foundation, urinary tract infection is second highly common infection globally and women are more prone to it. According to the Foundation, around 30 million adults suffer from chronic kidney diseases. Furthermore, rise in awareness regarding various infectious diseases and their treatment is propelling the growth of the global Amoxicillin market.

Special regulatory provisions and higher efficacy of Amoxicillin toward urinary tract infections and upper and lower respiratory infections are the other key factors driving the global Amoxicillin market. However, growing antibiotic resistance and slow registration process of national regulation authorities are anticipated to affect the growth of the global Amoxicillin market during the forecast period.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=54807

The global Amoxicillin market can be segmented based on dosage form, indication, distribution channel, and region. In terms of dosage form, the global Amoxicillin market can be classified into capsule, tablet, and suspension. The tablet segment dominates the Amoxicillin market and is expected to retain its position during the forecast period owing to low cost of the tablet as compared to that of the other oral dosage forms, storage convenience as tablet form does not require refrigeration and ease of administration being unit dosage form.

On the basis of indication, the global Amoxicillin market can be divided into respiratory tract infection, skin infection, chest infection, ear infection, urinary tract or kidney infection, bacterial endocarditis, and others. Respiratory tract infection is expected to dominate the market due to rise in prevalence of respiratory diseases, such as, pneumonia among children and efficacy of Amoxicillin against this disease. In terms of distribution channel, the global Amoxicillin market can be categorized into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies held a major share of the market due to their easy access and wide availability across regions.

Pre Book Amoxicillin Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=54807&ltype=S

In terms of regions, the global Amoxicillin market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global Amoxicillin market, followed by Europe. Rise in prevalence of respiratory infections, increase in awareness regarding bacterial infections and antibiotics, and presence of major players are likely to drive the Amoxicillin market in North America. The Amoxicillin market in Asia Pacific is expected to expand at a significant CAGR in the near future due to improved supply of the drug by major players and high growth in population in emerging countries, such as, Japan, China, and India.

The global Amoxicillin market is highly competitive and fragmented due to the large number of companies operating in the market. Key players operating in the global Amoxicillin market include CSPC Pharmaceutical Group Limited, GlaxoSmithKline plc, Merck KGaA, NCPC Xianati, Sandoz AG, Sinopharm Weiqida, Sun Pharmaceuticals Industries Limited, Teva Pharmaceuticals USA, Inc., United Laboratories, and DAEWOONG CO.LTD.

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/